Clinical Trials in Acute Lymphoblastic Leukaemia (ALL)

 

Trial Name

 

Trial Summary

 

Hyperlink

SeluDex

This trial compares selumetinib and dexamethasone for patients diagnosed with ALL

ALL-CAR19

A phase I, gene therapy trial for relapsed/refractory patients with B-ALL who are positive for the marker CD19.

ALL-RIC

A comparison of reduced dose total body irradiation (TBI) and cyclophosphamide with fludarabine and melphalan reduced intensity conditioning in adults with acute lymphoblastic leukaemia (ALL) in complete remission